The Recall Desk
Agency classClass IOur severity:SevereFDA (Devices)·Z-2577-2020·Announced 2020-07-22

CME America BodyGuard Microset Infusion Sets Recalled for Delivery Inaccuracy

CME America is recalling BodyGuard Microset infusion sets because they may deliver therapy at inaccurate rates, potentially causing over- or under-infusion.

The agency’s classification

FDA (Devices): Class I

Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classified this recall as Class I — a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. On that classification alone this is scored Severe; a score of Critical is reserved for recalls where a death or serious injury was reported. The agency gives the reason as: "Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy"

Plain-English summary

CME America, LLC is recalling 29,720 units of BodyGuard Microset infusion administration sets (REF: A120-160GCFA). The recall covers all lots within their expiry dates.

The recall was initiated because the infusion administration sets may have a delivery inaccuracy ranging from minus 42.8% to plus 17.5%, which exceeds the acceptable plus/minus 13% threshold. This inaccuracy could result in the over-infusion or under-infusion of therapy when used with an infusion pump system.

The affected products were distributed in the United States (including California, Indiana, Louisiana, Missouri, Florida, Illinois, Maine, Minnesota, Colorado, Virginia, Oklahoma, Nebraska, Georgia, Alabama, Kentucky, Iowa, Mississippi, Idaho, Texas, South Carolina, Ohio, South Dakota, Nevada, Michigan, Wyoming, North Carolina, Pennsylvania, Tennessee, Kansas, New Jersey, Oregon, Arkansas, New Mexico, Massachusetts, New York, District of Columbia, Rhode Island, Maryland, Washington, Wisconsin, Arizona, New Hampshire, Utah, Hawaii, Alaska, Montana, North Dakota, and Vermont) and in Canada and the United Kingdom. Consumers and healthcare providers should stop using these specific infusion sets and contact CME America, LLC for further instructions.

The recalled product

Product
BodyGuard Microset, REF: A120-160GCFA
Manufacturer
CME America, LLC
Category
Medical Device — Infusion Sets
Hazard
Affected units
29,720

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots within expiry

Distribution

Distributed in 49 states:

Part of a larger recall action

This product is one of 37 recalled by CME America, LLC under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 37 products in this recall →

Related recalls

Same manufacturer · CME America, LLC

See all →

Same hazard · delivery inaccuracy

See all →

Similar recalls